Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study.
Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S, Shinotoh H, Shimada H, Suhara T, Terada H, Nakatsuka T, Kawakatsu S, Hayashi H, Asada T, Ono T, Goto T, Shigemori K. Matsuda H, et al. Among authors: kawakatsu s. Neuropsychiatr Dis Treat. 2019 Sep 19;15:2715-2722. doi: 10.2147/NDT.S222966. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31571887 Free PMC article.
Prevalence and subtype distribution of early-onset dementia in Japan.
Awata S, Edahiro A, Arai T, Ikeda M, Ikeuchi T, Kawakatsu S, Konagaya Y, Miyanaga K, Ota H, Suzuki K, Tanimukai S, Utsumi K, Kakuma T. Awata S, et al. Among authors: kawakatsu s. Psychogeriatrics. 2020 Nov;20(6):817-823. doi: 10.1111/psyg.12596. Epub 2020 Aug 19. Psychogeriatrics. 2020. PMID: 32815229
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.
Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H. Kondo T, et al. Among authors: kawakatsu s. BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343. BMJ Open. 2021. PMID: 34193504 Free PMC article. Clinical Trial.
[DIAN/DIAN-J/DIAN-TU].
Shimada H, Shoji M, Ikeuchi T, Suzuki K, Senda M, Ishii K, Matsuda H, Iwata A, Ihara R, Iwatsubo T, Mutoh K, Nakazawa E, Sekijima Y, Mori E, Ikeda M, Ikeda M, Kawakatsu S, Nakanishi A, Hashimoto M, Nunomura A, Matsubara E, Fukui M, Shirato T, Hirai K, Sakamoto M, Fujii H, Mori H. Shimada H, et al. Among authors: kawakatsu s. Brain Nerve. 2017 Jul;69(7):701-709. doi: 10.11477/mf.1416200811. Brain Nerve. 2017. PMID: 28739983 Japanese.
Initial symptoms of early-onset dementia in Japan: nationwide survey.
Edahiro A, Okamura T, Arai T, Ikeuchi T, Ikeda M, Utsumi K, Ota H, Kakuma T, Kawakatsu S, Konagaya Y, Suzuki K, Tanimukai S, Miyanaga K, Awata S. Edahiro A, et al. Among authors: kawakatsu s. Psychogeriatrics. 2023 May;23(3):422-433. doi: 10.1111/psyg.12949. Epub 2023 Feb 22. Psychogeriatrics. 2023. PMID: 36814116
123 results